Letter to the Editor From Raschi et al: "Endocrine Adverse Reactions of Tyrosine Kinase Inhibitors in Combination With Immune Checkpoint Inhibitors"

Emanuel Raschi¹, Monia Donati¹, Francesco Salvo^{2

3}, Charles Khouri^{4

5}

Affiliations

¹ Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Bologna I-40126, Italy.
² Bordeaux Population Health, Team AHeaD, INSERM, Université de Bordeaux, U1219, Bordeaux F-33000, France.
³ Service de Pharmacologie Médicale, Centre Régional de Pharmacovigilance Bordeaux-DROM, CHU de Bordeaux, U1219, Bordeaux F-33000, France.
⁴ Pharmacovigilance Department Unit, Grenoble Alpes University Hospital, Grenoble F-38000, France.
⁵ HP2 Laboratory, University Grenoble Alpes, INSERM U1300, Grenoble F-38000, France.

Editorial

Emanuel Raschi et al. J Clin Endocrinol Metab. 2025.

. 2025 Sep 16;110(10):e3541-e3542.

doi: 10.1210/clinem/dgaf343.

Emanuel Raschi¹, Monia Donati¹, Francesco Salvo^{2

3}, Charles Khouri^{4

5}

¹ Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Bologna I-40126, Italy.
² Bordeaux Population Health, Team AHeaD, INSERM, Université de Bordeaux, U1219, Bordeaux F-33000, France.
³ Service de Pharmacologie Médicale, Centre Régional de Pharmacovigilance Bordeaux-DROM, CHU de Bordeaux, U1219, Bordeaux F-33000, France.
⁴ Pharmacovigilance Department Unit, Grenoble Alpes University Hospital, Grenoble F-38000, France.
⁵ HP2 Laboratory, University Grenoble Alpes, INSERM U1300, Grenoble F-38000, France.

No abstract available

Comment in

Response to Letter to the Editor From Raschi et al: "Endocrine Adverse Reactions of Tyrosine Kinase Inhibitors in Combination With Immune Checkpoint Inhibitors".
Shao W, Yang K, Lu D, Gao Y, Zhang J, Zhang Y. Shao W, et al. J Clin Endocrinol Metab. 2025 Sep 16;110(10):e3545-e3546. doi: 10.1210/clinem/dgaf344. J Clin Endocrinol Metab. 2025. PMID: 40519040 No abstract available.

Response to Letter to the Editor From Raschi et al: "Endocrine Adverse Reactions of Tyrosine Kinase Inhibitors in Combination With Immune Checkpoint Inhibitors".
Shao W, Yang K, Lu D, Gao Y, Zhang J, Zhang Y. Shao W, et al. J Clin Endocrinol Metab. 2025 Sep 16;110(10):e3545-e3546. doi: 10.1210/clinem/dgaf344. J Clin Endocrinol Metab. 2025. PMID: 40519040 No abstract available.